Cardiac Dimensions raises $35M Series D for mitral contour system

The Carillon system. [Image courtesy of Cardiac Dimensions]Heart failure treatment developer Cardiac Dimensions announced today that closed a $35 million Series D financing round.

Kirkland, Washington-based Cardiac Dimensions develops minimally invasive treatment modalities for heart failure and related cardiovascular conditions. Its lead product, the Carillon Mitral Contour System, uses a gentle, minimally invasive approach. It designed the system to restore natural mitral valve function without damaging mitral valve leaflets.

According to a news release, the device offers favorable remodeling while reducing mitral regurgitation. Cardiac Dimensions said it improves quality of life and extends survival for a range of patients.

Carillon produces an annuloplasty effect while initiating left ventricular remodeling and improving long-term survival. It can accompany other heart failure treatments if needed, Cardiac Dimensions said.

Existing investor Horiz…

Read more
  • 0